Boston Scientific Adds More Non-Vascular Stents To MedSurg Business With MI Tech Acquisition

 
• By Reed Miller

Boston Scientific will pay about $230m for 64% of Korea-based MI Tech, which developed the Hanarostent line of conformable, self-expanding metal stents for endoscopic and urologic applications.

Korea and US Flags
• Source: Shutterstock

More from Deals

More from Business